Mobile

A proof of concept study of the effects of QAX576 (an interleukin-13 monoclonal antibody) on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with se...

Update Il y a 4 ans
Reference: EUCTR2007-003403-13

A proof of concept study of the effects of QAX576 (an interleukin-13 monoclonal antibody) on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess the ability of QAX576 to inhibit inflammation from nasal allergen exposure (Timothy Grass Pollen) as assessed by Th2-associated cytokines in nasal secretions.

Inclusion criteria

  • Seasonal Allergic Rhinitis

Links